Mega Genomics Limited
6667.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.6B
Close$
$8.12
14.7% upside
Current Fair Value
14.7% upsideUndervalued by 14.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.60 Billion |
|---|---|
| Enterprise Value | $1.21 Billion |
| Dividend Yield | $0.17 (2.38%) |
| Earnings per Share | $0.13 |
| Beta | 0.76 |
| Outstanding Shares | 204,426,610 |
Return
| Return on Equity | 9.89% |
|---|---|
| Return on Assets | 7.22% |
| Return on Invested Capital | 10.32% |
Valuation & Multiples
| P/E Ratio | 51.19 |
|---|---|
| PEG | -529.15 |
| Price to Sales | 3.54 |
| Price to Book Ratio | 3.54 |
| Enterprise Value to Revenue | 2.45 |
| Enterprise Value to EBIT | 18.74 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Mega Genomics Limited
196 employees
CEO: Jing Jiang Mega Genomics Limited, a genetic testing platform company, offers consumer genetic testing and cancer screening services in China. It offers brain health assessment package, a service that assesses the risk of various related diseases, i...